Skip to Main Content

Paper Details

Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.
Circulation
174
2017
GMT, Gata4, Human, Mef2c, SB431542, Tbx5, WNT, XAV939, beating cells, cardiac fibroblasts, cardiomyocyte, cardiomyocyte-like cells, fibroblasts, induced cardiomyocyte-like cells, mice, myocardial infarction, myocardin, primary cardiac fibroblasts, transforming
Author NameAffiliation
Nicole R StoneFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Yu HuangFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Yen-Sin AngFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Yen-Sin AngFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Pengzhi YuFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Kathryn N IveyFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco.
Deepak SrivastavaFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco. .
Deepak SrivastavaFrom Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, D.S.) Institute of Cardiovascular Sciences, University of Manchester, UK (T.M.A.M.) Faculty of Pharmacy, Zagazig University, University of California San Francisco. .
  • 1 - 8

Datasets

Release 1.2